XML 82 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation Pre-tax Income
A reconciliation of the Company’s
pre-tax
loss for the years ended December 31, 2022 and 2021 is as follows:
 
    
2022
    
2021
 
Domestic
   $ (81,586    $ (84,624
Foreign
     4        (47
  
 
 
    
 
 
 
Total
   $ (81,582    $ (84,671
  
 
 
    
 
 
 
Schedule of Provision
The Company’s provision at December 31, 2022 and 2021 consist of the following:
 
                         
    
2022
    
2021
 
Current:
     
Federal
  
$
—  
 
  
$
—  
 
State
  
 
(2
  
 
15
 
Foreign
  
 
—  
 
  
 
—  
 
  
 
 
    
 
 
 
Total current
  
$
(2
  
$
15
 
Deferred:
     
Federal
  
 
—  
 
  
 
—  
 
State
  
 
—  
 
  
 
—  
 
Foreign
  
 
—  
 
  
 
—  
 
  
 
 
    
 
 
 
Total deferred
  
$
—  
 
  
$
—  
 
  
 
 
    
 
 
 
Total (benefit) provision
  
$
(2
  
$
15
 
Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate
A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate for the years ended December 31, 2022 and 2021 is as follows:
 
                         
    
2022
   
2021
 
U.S federal statutory income tax rate
  
 
21.0
 
 
21.0
Permanent differences
  
 
(0.1
 
 
—  
 
State income taxes, net of federal benefit
  
 
5.4
 
 
 
2.7
 
Research and development tax credits
  
 
5.1
 
 
 
3.6
 
State rate changes
  
 
3.7
 
 
 
—  
 
Stock compensation deductions
  
 
(2.8
 
 
1.6
 
Other items
  
 
—  
 
 
 
(0.7
Change in deferred tax asset valuation allowance
  
 
(32.3
 
 
(28.2
  
 
 
   
 
 
 
Effective income tax rate
  
 
—  
 
 
—  
  
 
 
   
 
 
 
Schedule of Deferred Tax Assets
The Company’s deferred tax assets at December 31, 2022 and 2021 consist of the following:
 
                         
    
2022
    
2021
 
Deferred tax assets:
     
Net operating loss carryforwards
  
$
45,512
 
  
$
36,590
 
Research and development tax credits
  
 
11,163
 
  
 
7,026
 
Capitalized research and development costs
  
 
10,042
 
  
 
—  
 
Intangibles
  
 
478
 
  
 
392
 
Stock compensation
  
 
9,507
 
  
 
6,554
 
Accrued expenses
  
 
—  
 
  
 
107
 
Deferred revenue
  
 
—  
 
  
 
—  
 
Other
  
 
357
 
  
 
176
 
Fixed assets
  
 
282
 
  
 
265
 
Lease liability
  
 
7,735
 
  
 
7,269
 
  
 
 
    
 
 
 
Gross deferred tax asset
  
 
85,076
 
  
 
58,379
 
Valuation allowance
  
 
(77,288
  
 
(50,931
  
 
 
    
 
 
 
Net deferred tax assets
  
$
7,788
 
  
$
7,448
 
Deferred tax liabilities:
     
Right of use asset
  
 
(7,788
  
 
(7,448
  
 
 
    
 
 
 
Net deferred tax asset (liability)
  
$
—  
 
  
$
—